Israeli medical cannabis company Cann10 has signed an agreement to team up with Israeli biotech company Epigenetics to form Cann10 EpiGen, a joint company focused on using cutting-edge epigenetics technology to make a version of the cannabis plant that is easier to cultivate and farm.
Cann10 and Epigenetics will jointly invest dozens of thousands of dollars to promote research of the cannabis plant using the new technology, with the purpose of improving the plant’s desirable traits and increasing the efficiency and quality of its growth
In the next few weeks, the first research using the new technology will begin under the cannabis farm run by Seach Medical Group, while the initial research results are expected to be revealed in six months time.
Epigenetics is a state-of-the-art third-generation breeding technology, that focuses on revealing hidden parts of the DNA of the plant and enabling select genes to manifest themselves.
Read more at jpost.com